GeneGo Licenses MetaCore Technology to Philips
News Aug 01, 2007
According to GeneGo, MetaCore is a flexible pathway analysis platform that can be utilized with or without experimental data. It contains a lot of domain and disease knowledge that is easily accessible to general users which answers day to day questions of what is upstream or downstream of this gene or how are these metabolites linked via pathways, relevant papers to specific diseases or all papers on a compound binding with a specific ligand.
"We are very pleased with Philips' decision to license MetaCore," said Julie Bryant, GeneGo's VP of Business Development. "We have seen a surge of diagnostic companies, such as Almac Diagnostics becoming GeneGo customers over the last couple of years, and Philips is the latest addition. We welcome the expansion of the scope of systems biology applications beyond drug discovery."
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.